Article
Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays.
Nature communications - 12 Jul 2022
Chen Lei, Eriksson Anna, Weström Simone, Pandzic Tatjana, Lehmann Sören, Cavelier Lucia, Landegren Ulf
Abstract excerpt
Rare tumor-specific mutations in patient samples serve as excellent markers to monitor the course of malignant disease and responses to therapy in clinical routine, and improved assay techniques are needed for broad adoption. We describe herein a highly sensitive and selective molecule amplification technology - superRCA assays - for rapid and highly specific detection of DNA sequence variants present at very low...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
